Google’s DeepMind to create product to spot eye disease

A Google sign is seen during the China Digital Entertainment Expo and Conference (ChinaJoy) in Shanghai, China August 3, 2018. REUTERS/Aly Song

DeepMind, the London-based artificial intelligence company that is owned by Alphabet Inc, plans to develop a medical product that will help doctors to detect more than 50 sight-threatening conditions from a common type of eye scan. 

DeepMind trained artificial intelligence software to detect signs of disease better than human doctors, according to a study published Monday in the scientific journal Nature Medicine. DeepMind and its partners in the research, London’s Moorfields Eye Hospital and the University College London Institute of Ophthalmology, said they plan prospective clinical trials of the technology in 2019.